Brisdelle, (paroxetine) has been approved by the U.S. Food and Drug Administration for the treatment of hot flashes due to menopause, and is the first non-hormonal treatment to be approved by the FDA.
While all other FDA approved treatments contain the hormones estrogen or progestin, Brisdelle contains the selective serotonin reuptake inhibitor paroxetine mesylate – making it unique from other treatments.

Hylton V. Joffe, M.D., M.M. Sc., director of the Division of Bone, Reproductive and Urologic Products in the FDA’s Center for Drug Evaluation and Research said: “There are a significant number of women who suffer from hot flashes associated with menopause and who cannot or do not want to use hormonal therapy. Today’s approval provides women with the first FDA approved, non-hormonal therapeutic option to help ease the hot flashes that are so common in menopause.”

Additionally, findings published in Menopause – the Journal of the North American Menopause Society indicate that two daily servings of soy can reduce the frequency and severity of hot flashes by up to 26%. And, the results of a randomized, controlled study, published in the journal Menopause found that hypnosis can minimize hot flashes by as much as 74%.       Medical News Today    June 30, 2013


Pin It on Pinterest